Related Experiment Video
Updated: May 28, 2026

Exercise Test for Evaluation of the Functional Efficacy of the Pig Cardiovascular System
Published on: May 12, 2023
Gene Therapy for Cardiovascular and Cerebrovascular Disease: Mechanisms, Translational Barriers, and the Road Ahead
Zixu Liu1, Ruiqi Liu1, Ying Ying2
1Queen Mary College, Jiangxi Medical College, Nanchang University, Nanchang 330006, China.
Insights
Gene therapy offers new hope for cardiovascular and cerebrovascular diseases like arrhythmias, atherosclerosis, and stroke. These advanced treatments target root causes, potentially transforming patient outcomes beyond conventional care.
Area of Science:
- Cardiovascular and cerebrovascular research
- Genetic medicine
- Translational science
Background:
- Cardiovascular and cerebrovascular diseases are leading causes of death and disability worldwide.
- Conventional therapies leave significant residual risk, necessitating novel interventions.
- Gene-based approaches offer potential to address underlying molecular pathology.
Purpose of the Study:
- To review current gene therapy strategies for cardiovascular and cerebrovascular diseases.
- To synthesize mechanistic understanding, translational obstacles, and future directions.
- To evaluate gene therapy's potential to complement standard care.
Main Methods:
- Review of gene-based interventions including KCNQ1/KCNH2 suppression, SCN5A base editing, PKP2/TMEM43 restoration for arrhythmias.
- Analysis of RNA-based agents (inclisiran) and in vivo editing (VERVE-101) for atherosclerosis.
- Examination of cGAS-STING silencing, AAV-NeuroD1 reprogramming, and neurotrophic factor delivery for ischemic stroke.
Main Results:
- Gene therapies show promise in stabilizing electrophysiology, reducing lipids, and attenuating vascular inflammation.
- Specific strategies like AAV-NeuroD1 and neurotrophic factors extend therapeutic windows post-stroke.
- These approaches address fundamental molecular causes, offering a new therapeutic paradigm.
Conclusions:
- Gene therapy presents a meaningful complement to existing treatments for cardiovascular and cerebrovascular diseases.
- Despite delivery and safety challenges, gene therapy is poised to significantly impact disease prevention and treatment.
- Addressing root molecular pathology offers a transformative potential for managing these conditions.
Abstract:
Cardiovascular and cerebrovascular diseases, encompassing cardiac arrhythmias, atherosclerosis, and ischaemic stroke, remain the foremost causes of death and long-term disability globally. Despite improved outcomes with conventional therapy, substantial residual risk persists, providing the impetus for gene-based intervention. KCNQ1/KCNH2 suppression-and-replacement, SCN5A base editing, and structural protein restoration via PKP2 and TMEM43 have each demonstrated capacity to re-establish electrophysiological stability in arrhythmia models. For atherosclerosis, RNA-based agents, notably inclisiran, alongside in vivo editing strategies such as VERVE-101, offer durable lipid reduction and attenuation of vascular inflammation. In ischaemic stroke, cGAS-STING silencing, AAV-NeuroD1-mediated neuronal reprogramming, and delivery of neurotrophic factors, including VEGF and BDNF, extend the therapeutic window well beyond reperfusion. Collectively, these approaches position gene therapy as a meaningful complement to standard care, capable of addressing root molecular pathology rather than downstream consequences. This review synthesises current mechanistic understanding, translational obstacles, and emerging directions across these three disease domains, arguing that, delivery and safety challenges notwithstanding, gene therapy stands to substantially reshape how cardiovascular and cerebrovascular diseases are prevented and treated.
Related Concept Videos
Pharmacogenomics: Identification of New Drug Targets
Microorganisms in Medicine and Therapeutics
Gene Therapy
Gene Therapy
Pharmacogenetics and Pharmacogenomics: Overview
Cardiovascular Drugs: Classification based on Therapeutic Indications

